日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy of cisplatin plus vinorelbine adjuvant chemotherapy with split-dose administration of cisplatin after complete resection of stage II-IIIA non-small cell lung cancer

顺铂联合长春瑞滨辅助化疗（顺铂分次给药）在II-IIIA期非小细胞肺癌完全切除术后的疗效

期刊:Molecular and Clinical Oncology
影响因子:1.4
doi:10.3892/mco.2022.2509
Funaguchi, Norihiko; Iihara, Hirotoshi; Kaito, Daizo; Gomyo, Takenori; Sasaki, Yuka; Yanase, Komei; Endo, Junki; Ito, Fumitaka; Hirose, Chiemi; Ohno, Yasushi; Okura, Hiroyuki
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial

低剂量奥氮平联合格拉司琼和地塞米松治疗卡铂引起的胸部恶性肿瘤患者恶心呕吐：一项前瞻性多中心II期试验

期刊:Oncologist
影响因子:4.2
doi:10.1002/onco.13772
Sakai, Chizuru; Shimokawa, Mototsugu; Iihara, Hirotoshi; Fujita, Yukiyoshi; Ikemura, Shinnosuke; Hirose, Chiemi; Kotake, Mie; Funaguchi, Norihiko; Gomyo, Takenobu; Imai, Hisao; Hakamata, Jun; Kaito, Daizo; Minato, Koichi; Arai, Takahiro; Kawazoe, Hitoshi; Suzuki, Akio; Ohno, Yasushi; Okura, Hiroyuki
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Evaluation of clinical pharmacist interventions for adverse events in hospitalized patients with thoracic cancer receiving cancer chemotherapy

评估临床药师干预措施对接受化疗的胸部肿瘤住院患者不良事件的影响

期刊:Molecular and Clinical Oncology
影响因子:1.4
doi:10.3892/mco.2021.2278
Iihara, Hirotoshi; Hirose, Chiemi; Funaguchi, Norihiko; Endo, Junki; Ito, Fumitaka; Yanase, Komei; Kaito, Daizo; Ohno, Yasushi; Suzuki, Akio
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Clinical trial protocol of doublet therapy and olanzapine for carboplatin-induced nausea and vomiting in patients with thoracic cancer: a multicentre phase II trial

双药联合奥氮平治疗卡铂诱发胸部肿瘤患者恶心呕吐的临床试验方案：一项多中心II期试验

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2018-028056
Iihara, Hirotoshi; Shimokawa, Mototsugu; Gomyo, Takenobu; Fujita, Yukiyoshi; Yoshida, Tsutomu; Funaguchi, Norihiko; Minato, Koichi; Kaito, Daizo; Osawa, Tomohiro; Yamada, Momoko; Hirose, Chiemi; Suzuki, Akio; Ohno, Yasushi
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases

对纳武利尤单抗在既往接受过治疗的晚期或复发性非小细胞肺癌病例中的多效性作用进行分析

期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.11503
Akano, Yumiko; Kuribayashi, Kozo; Funaguchi, Norihiko; Koda, Yuichi; Fujimoto, Eriko; Mikami, Koji; Minami, Toshiyuki; Takahashi, Ryo; Yokoi, Takashi; Kijima, Takashi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Immune thrombocytopenia induced by nivolumab in a patient with non-small cell lung cancer

非小细胞肺癌患者接受纳武利尤单抗治疗后出现免疫性血小板减少症

期刊:Respiratory Medicine Case Reports
影响因子:0.7
doi:10.1016/j.rmcr.2019.100871
Mori, Hidenori; Sakai, Chizuru; Iwai, Masamichi; Sasaki, Yuka; Gomyo, Takenobu; Toyoshi, Sayaka; Kaito, Daizo; Yanase, Komei; Ito, Fumitaka; Endo, Junki; Funaguchi, Norihiko; Ohno, Yasushi; Minatoguchi, Shinya
血小板
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2019
文献求助 收藏

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

恶性胸膜间皮瘤的早期临床特征

期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.11360
Negi, Yoshiki; Kuribayashi, Kozo; Funaguchi, Norihiko; Doi, Hiroshi; Mikami, Koji; Minami, Toshiyuki; Takuwa, Teruhisa; Yokoi, Takashi; Hasegawa, Seiki; Kijima, Takashi
发表日期：2018
文献求助 收藏

Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection

呼吸道感染患者连续口服莫西沙星（400 mg/天）的药代动力学

期刊:Therapeutic Advances in Respiratory Disease
影响因子:3
doi:10.1177/1753465815620338
Ito, Fumitaka; Ohno, Yasushi; Toyoshi, Sayaka; Kaito, Daizo; Koumei, Yanase; Endo, Junki; Kamamiya, Fumihiko; Mori, Hidenori; Mori, Masahiro; Morishita, Megumi; Funaguchi, Norihiko; Minatoguchi, Shinya
炎症/感染
发表日期：2016
文献求助 收藏